Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma.
Yinan HuJingyi LiuJiahao YuFangfang YangMiao ZhangYansheng LiuShuoyi MaXia ZhouJingbo WangYing HanPublished in: Cancer cell international (2022)
In conclusion, our CMGs-related risk signature could be used as a prediction tool in survival assessment and immunotherapy for HCC patients.